Literature DB >> 29761365

Visual Rating and Computer-Assisted Analysis of FDG PET in the Prediction of Conversion to Alzheimer's Disease in Mild Cognitive Impairment.

Jae Myeong Kang1, Jun-Young Lee2,3, Yu Kyeong Kim4,5, Bo Kyung Sohn6, Min Soo Byun7,8, Ji Eun Choi9, Soo Kyung Son9, Hyung-Jun Im10, Jae-Hoon Lee11, Young Hoon Ryu11, Dong Young Lee7,8.   

Abstract

BACKGROUND: Fluorodeoxyglucose (FDG) positron emission tomography (PET) is useful to predict Alzheimer's disease (AD) conversion in patients with mild cognitive impairment (MCI). However, few studies have examined the extent to which FDG PET alone can predict AD conversion and compared the efficacy between visual and computer-assisted analysis directly.
OBJECTIVE: The current study aimed to evaluate the value of FDG PET in predicting the conversion to AD in patients with MCI and to compare the predictive values of visual reading and computer-assisted analysis. METHODS AND MATERIALS: A total of 54 patients with MCI were evaluated with FDG PET and followed-up for 2 years with final diagnostic evaluation. FDG PET images were evaluated by (1) traditional visual rating, (2) composite score of visual rating of the brain cortices, and (3) composite score of computer-assisted analysis. Receiver operating characteristics (ROC) curves were compared to analyze predictive values.
RESULTS: Nineteen patients (35.2%) converted to AD from MCI. The area under the curve (AUC) of the ROC curve of the traditional visual rating, composite score of visual rating, and computer-assisted analysis were 0.67, 0.76, and 0.79, respectively. ROC curves of the composite scores of the visual rating and computer-assisted analysis were comparable (Z = 0.463, p = 0.643).
CONCLUSIONS: Visual rating and computer-assisted analysis of FDG PET scans were analogously accurate in predicting AD conversion in patients with MCI. Therefore, FDG PET may be a useful tool for screening AD conversion in patients with MCI, when using composite score, regardless of the method of interpretation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29761365     DOI: 10.1007/s40291-018-0334-z

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  34 in total

1.  The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: A retrospective memory clinic study.

Authors:  Robert Laforce; James P Buteau; Nancy Paquet; Louis Verret; Michèle Houde; Rémi W Bouchard
Journal:  Am J Alzheimers Dis Other Demen       Date:  2010-06       Impact factor: 2.035

2.  Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Kewei Chen; Jessica B S Langbaum; Adam S Fleisher; Napatkamon Ayutyanont; Cole Reschke; Wendy Lee; Xiaofen Liu; Dan Bandy; Gene E Alexander; Paul M Thompson; Norman L Foster; Danielle J Harvey; Mony J de Leon; Robert A Koeppe; William J Jagust; Michael W Weiner; Eric M Reiman
Journal:  Neuroimage       Date:  2010-03-02       Impact factor: 6.556

3.  Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.

Authors:  Kengo Ito; Hidenao Fukuyama; Michio Senda; Kazunari Ishii; Kiyoshi Maeda; Yasuji Yamamoto; Yasuomi Ouchi; Kenji Ishii; Ayumu Okumura; Ken Fujiwara; Takashi Kato; Yutaka Arahata; Yukihiko Washimi; Yoshio Mitsuyama; Kenichi Meguro; Mitsuru Ikeda
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.

Authors:  Davide Anchisi; Barbara Borroni; Massimo Franceschi; Nasser Kerrouche; Elke Kalbe; Bettina Beuthien-Beumann; Stephano Cappa; Olaf Lenz; Stephan Ludecke; Alessandra Marcone; Rüdiger Mielke; Paola Ortelli; Alessandro Padovani; Oriana Pelati; Alberto Pupi; Elio Scarpini; Simon Weisenbach; Karl Herholz; Erik Salmon; Vjera Holthoff; Sandro Sorbi; Ferruccio Fazio; Daniela Perani
Journal:  Arch Neurol       Date:  2005-11

5.  Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study.

Authors:  Silvia Morbelli; Arnoldo Piccardo; Giampiero Villavecchia; Barbara Dessi; Andrea Brugnolo; Alessandra Piccini; Anna Caroli; Giovanni Frisoni; Guido Rodriguez; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

Review 6.  Loss of motor function in preclinical Alzheimer's disease.

Authors:  Aron S Buchman; David A Bennett
Journal:  Expert Rev Neurother       Date:  2011-05       Impact factor: 4.618

Review 7.  Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment.

Authors:  S Zhang; D Han; X Tan; J Feng; Y Guo; Y Ding
Journal:  Int J Clin Pract       Date:  2012-02       Impact factor: 2.503

Review 8.  Mild cognitive impairment: believe it or not?

Authors:  Ricardo F Allegri; Frank B Glaser; Fernando E Taragano; Herman Buschke
Journal:  Int Rev Psychiatry       Date:  2008-08

Review 9.  Alzheimer disease: operating characteristics of PET--a meta-analysis.

Authors:  Meenal B Patwardhan; Douglas C McCrory; David B Matchar; Gregory P Samsa; Olivier T Rutschmann
Journal:  Radiology       Date:  2004-02-27       Impact factor: 11.105

10.  Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment.

Authors:  Jonathan Young; Marc Modat; Manuel J Cardoso; Alex Mendelson; Dave Cash; Sebastien Ourselin
Journal:  Neuroimage Clin       Date:  2013-05-19       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.